Is there a metabolic effect of continuous positive airway pressure in sleep apnoea? Adherence should not be underestimated

European Respiratory Journal

Volumn 34, Issue 5, 2009, Pages 1209-1210

  Steiropoulos, P ^a   Papanas, N ^a   Maltezos, E ^a   Bouros, D ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLOW UP; GLYCEMIC CONTROL; LETTER; METABOLISM; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; OBESITY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP APNEA SYNDROMES; TIME FACTORS; TREATMENT OUTCOME;

EID: 71049119494     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00108109     Document Type: Letter

References (5)

1. Lévy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34: 243-260.
2. West SD, Nicoll DJ, Wallace TM, et al. The effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007; 62: 969-974.
3. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese men with OSA. Eur Respir J 2007; 29: 720-727. (Pubitemid 46554622)
4. Steiropoulos P, Tsara V, Nena E, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2007; 132: 843-851.
5. Steiropoulos P, Papanas N, Nena E, et al., Markers of glycemic control and insulin resistance in non-diabetic patients with obstructive sleep apnea hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control? Sleep Med 2009; 10: 887-891.